Convatec today announced the launch of a new research hub in Manchester, committing £500 million to enhance its medical device innovation and R&D capabilities. The facility, scheduled to open in 2027, will consolidate teams across wound care, ostomy care, continence care, and infusion devices, providing a central location to accelerate the development of advanced healthcare technologies. This step underscores Convatec’s dedication to improving patient outcomes and strengthening its global innovation footprint.
Research Hub Strengthens Innovation Efforts
The Manchester research hub will accommodate approximately 200 employees, including engineers, scientists, and regulatory experts. Teams relocating from Convatec’s Deeside site will work alongside newly hired specialists to foster collaboration and streamline innovation pipelines. The facility will centralize early concept development, clinical validation, and integration of digital health solutions. By unifying expertise under one roof, Convatec aims to reduce development cycles and enhance the speed of delivering new medical devices to market.
Manchester Center Supports Life Sciences Collaboration
Manchester’s thriving life sciences ecosystem makes it an ideal location for Convatec’s new facility. Partnerships with local universities, hospitals, and research institutions will facilitate translational research and collaborative projects. The research hub is also expected to generate high-skilled employment opportunities, expand training programs, and strengthen the local biomedical workforce. These efforts will not only enhance Convatec’s capabilities but also contribute to the broader healthcare innovation community across the UK and Europe.
Global R&D Expansion and Strategy
The Manchester initiative forms a crucial part of Convatec’s global R&D strategy, complementing facilities in the United States. Consolidating teams and capabilities in a single location will optimize operations in regulatory compliance, clinical research, and digital analytics. This approach is designed to support the development of next-generation medical devices and innovative patient solutions worldwide. By improving coordination between engineering, clinical, and regulatory functions, the research hub will enable faster translation of ideas into market-ready products.
Driving Healthcare Technology Forward
The Manchester center will feature advanced analytical labs, device testing suites, and digital health platforms. Bringing together multidisciplinary teams will streamline development processes, reduce duplication, and maintain the highest quality and safety standards. The research hub reinforces Convatec’s leadership in medical device innovation while ensuring that patients benefit from state-of-the-art healthcare solutions. The facility is expected to be a benchmark for industry standards, inspiring collaboration across global R&D networks.
By investing in the Manchester research hub, Convatec demonstrates its long-term commitment to innovation, workforce development, and patient-focused healthcare technology. The facility will also provide opportunities for graduate placements, internships, and collaboration with academic partners, ensuring a continuous pipeline of skilled talent to support ongoing research and development initiatives.
